Cart
sales@molnova.com
Secretin (33-59), rat
CAS No. 121028-49-7
Secretin (33-59), rat( —— )
Catalog No. M29738 CAS No. 121028-49-7
Secretin (33-59), rat is a 27-aa peptide, acts on secretin receptor, enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 174 | In Stock |
|
| 10MG | 257 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 535 | In Stock |
|
| 100MG | 723 | In Stock |
|
| 200MG | 958 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSecretin (33-59), rat
-
NoteResearch use only, not for human use.
-
Brief DescriptionSecretin (33-59), rat is a 27-aa peptide, acts on secretin receptor, enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas.
-
DescriptionSecretin (33-59), rat is a 27-aa peptide, acts on secretin receptor, enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSecretin receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number121028-49-7
-
Formula Weight3027.35
-
Molecular FormulaC129H216N42O42
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Muscimol HBr
Muscimol HBr is an agonist of GABAA receptor.
-
trans-Isoferulic aci...
Isoferulic acid is an effective natural antioxidant in both lipid and aqueous media, it may be a new promising anti-glycation agent for the prevention of diabetic complications via inhibition of advanced glycation end products (AGEs) formation and oxidation-dependent protein damage.
-
PAR-4 Agonist Peptid...
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP TFA; AY-NH2 TFA) is a proteinase-activated receptor-4 (PAR-4) agonist, which has no effect on either PAR-1 or PAR-2 and whose effects are blocked by a PAR-4 antagonist.
